Department of Chemistry, Koç University, Sariyer, Istanbul 34450, Turkey.
Molecular Cancer Research Center, Istinye University Istanbul 34010, Turkey.
Bioorg Chem. 2022 May;122:105725. doi: 10.1016/j.bioorg.2022.105725. Epub 2022 Mar 17.
A cysteine (Cys) activatable chlorinated hemicyanine (Cl-Cys) was introduced as a tumour selective image-guided dual phototherapy agent. Cl-Cys exhibited a significant turn on response in its near-IR emission signal and activated its singlet oxygen generation as well as photothermal conversion potentials upon reacting with Cys. The laser irradiation of Cl-Cys induced significant cell death in cancer cells with high Cys level, while it stayed deactivated and non-emissive in a healthy cell line. A profound synergistic PDT/PTT effect was observed at high doses. Remarkably, Cl-Cys marks the first ever example of Cys-responsive small organic-based therapeutic agent and holds a great promise to develop new activity-based photosensitizers for dual phototherapy action.
一种半胱氨酸(Cys)激活的氯化杂环菁(Cl-Cys)被引入作为一种肿瘤选择性的图像引导的双重光疗试剂。Cl-Cys 在其近红外发射信号中表现出显著的开启响应,并在与 Cys 反应时激活其单线态氧生成和光热转换潜能。Cl-Cys 的激光照射在 Cys 水平高的癌细胞中诱导了显著的细胞死亡,而在健康细胞系中它保持失活和非发光状态。在高剂量下观察到显著的协同 PDT/PTT 效应。值得注意的是,Cl-Cys 是第一个 Cys 响应的小分子有机治疗剂的例子,为开发用于双重光疗作用的基于活性的光敏剂提供了很大的希望。